GBL stock clears Recordati threshold with CVC for delisting path

Groupe Bruxelles Lambert and private-equity firm CVC secured more than 90 percent of Recordati at the end of the takeover offer period, Reuters reported on November 9, 2026. The result clears the regulatory threshold for a squeeze-out of remaining minority shareholders and creates a path toward delisting the Italian pharmaceutical company from Euronext Milan.

Recordati enters the next phase

The crossing of the threshold gives the offeror access to the compulsory purchase mechanisms under Italian takeover law. Recordati shareholders who did not tender their shares may therefore face a subsequent buyout process, while the remaining listed shares could be removed from trading after the required steps are completed.

The transaction matters for GBL because Recordati is part of its investment portfolio. Moving the holding from a listed position into a privately controlled company could change how the asset is reflected in GBL's future net asset value. The effect will depend on the final transaction terms and the valuation applied after completion.

Investment holding with global portfolio

GBL is a Brussels-based investment holding company with investments across listed and private businesses. Its portfolio includes interests in sectors such as pharmaceuticals, consumer goods and industrial activities, giving the group broader exposure than a single-industry company.

In the European investment-company segment, GBL competes for shareholder capital with diversified groups such as Eurazeo, Wendel and Investor AB. GBL is distinguished by its Belgian base and its mix of listed holdings and direct private investments.

European equity markets remain the broader backdrop for diversified investment companies. Current Euro Stoxx 50 market reports provide the relevant regional context.

More news and analyses on Groupe Bruxelles Lambert stock